316 related articles for article (PubMed ID: 33504104)
1. The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
Torre BG; Albericio F
Molecules; 2021 Jan; 26(3):. PubMed ID: 33504104
[TBL] [Abstract][Full Text] [Related]
2. The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
de la Torre BG; Albericio F
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164339
[TBL] [Abstract][Full Text] [Related]
3. The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules.
de la Torre BG; Albericio F
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770706
[TBL] [Abstract][Full Text] [Related]
4. The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
de la Torre BG; Albericio F
Molecules; 2020 Feb; 25(3):. PubMed ID: 32050446
[TBL] [Abstract][Full Text] [Related]
5. The Pharmaceutical Industry in 2023: An Analysis of FDA Drug Approvals from the Perspective of Molecules.
de la Torre BG; Albericio F
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338330
[TBL] [Abstract][Full Text] [Related]
6. The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
G de la Torre B; Albericio F
Molecules; 2019 Feb; 24(4):. PubMed ID: 30813407
[TBL] [Abstract][Full Text] [Related]
7. The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
de la Torre BG; Albericio F
Molecules; 2018 Feb; 23(3):. PubMed ID: 29495494
[TBL] [Abstract][Full Text] [Related]
8. The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type.
Torre BG; Albericio F
Molecules; 2017 Feb; 22(3):. PubMed ID: 28264468
[TBL] [Abstract][Full Text] [Related]
9. 2021 FDA TIDES (Peptides and Oligonucleotides) Harvest.
Al Shaer D; Al Musaimi O; Albericio F; de la Torre BG
Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215334
[TBL] [Abstract][Full Text] [Related]
10. FDA Approval and Regulation of Pharmaceuticals, 1983-2018.
Darrow JJ; Avorn J; Kesselheim AS
JAMA; 2020 Jan; 323(2):164-176. PubMed ID: 31935033
[TBL] [Abstract][Full Text] [Related]
11. FDA Approvals of Biologics in 2022.
Martins AC; Albericio F; de la Torre BG
Biomedicines; 2023 May; 11(5):. PubMed ID: 37239105
[TBL] [Abstract][Full Text] [Related]
12. 2023 in review: FDA approvals of new medicines.
Kinch MS; Kraft Z; Schwartz T
Drug Discov Today; 2024 May; 29(5):103966. PubMed ID: 38552777
[TBL] [Abstract][Full Text] [Related]
13. Recent drug approvals from the US FDA and EMEA: what the future holds.
Pevarello P
Future Med Chem; 2009 Apr; 1(1):35-48. PubMed ID: 21426069
[TBL] [Abstract][Full Text] [Related]
14. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
15. 2018 in review: FDA approvals of new molecular entities.
Kinch MS; Griesenauer RH
Drug Discov Today; 2019 Sep; 24(9):1710-1714. PubMed ID: 31158510
[TBL] [Abstract][Full Text] [Related]
16. Combination products regulation at the FDA.
Lauritsen KJ; Nguyen T
Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151
[TBL] [Abstract][Full Text] [Related]
17. US-FDA Approved Drugs in 2020 and 2021: A Review.
Passi I; Salwan S; Kumar B
Mini Rev Med Chem; 2023; 23(12):1273-1297. PubMed ID: 36503454
[TBL] [Abstract][Full Text] [Related]
18. 2022 in review: FDA approvals of new medicines.
Kinch MS; Kraft Z; Schwartz T
Drug Discov Today; 2023 Aug; 28(8):103622. PubMed ID: 37201782
[TBL] [Abstract][Full Text] [Related]
19. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
DiMasi JA
Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
[TBL] [Abstract][Full Text] [Related]
20. Ophthalmic Drug Discovery in the United States over the past Two Decades.
Gu D; Janetos TM
Ophthalmic Epidemiol; 2021 Feb; 28(1):21-26. PubMed ID: 32597285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]